After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Quest Diagnostics, Inc. is listed on the NYSE in the Healthcare sector while operating in the Diagnostics & Research industry. The current market capitalization of Quest Diagnostics, Inc. is $16.94B. A total of 0.56 million shares were traded on the day, compared to an average of 821.39K shares.
In the most recent transaction, PREVOZNIK MICHAEL E sold 32,551 shares of DGX for 154.97 per share on Aug 29 ’24. After the transaction, the SVP & General Counsel now owns 38,478 company shares. In a previous transaction on Aug 28 ’24, KUPPUSAMY KARTHIK sold 1,990 shares at 153.26 per share. DGX shares that SVP, Clinical Solutions owns now total 11,459.
Among the insiders who bought shares, PREVOZNIK MICHAEL E acquired of 32,551 shares on Aug 29 ’24 at a per-share price of $154.97. In another insider transaction, KUPPUSAMY KARTHIK bought 1,990 shares at $153.26 per share on Aug 28 ’24.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Quest Diagnostics, Inc. pays an annual dividend of $2.92, resulting in a dividend yield of 1.92%, and it has a price to earnings (P/E) ratio of 20.52. DGX’s most recent ex-dividend date was 10/4/2024 when it declared a $0.75 quarterly dividend that was paid in cash on 10/21/2024. Previously, the company paid the dividend on 7/22/2024 with an ex-dividend date of 7/8/2024. The DGX stock dividend was $0.75 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, DGX has a high of $159.36 and a low of $120.10.
As of this writing, DGX has an earnings estimate of $2.27 per share for the current quarter. EPS was calculated based on a consensus of 16.0 estimates, with a high estimate of $2.36 per share and a lower estimate of $2.22. The company reported an EPS of $2.22 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. DGX’s latest balance sheet shows that the firm has $872.00M in Cash & Short Term Investments as of fiscal 2021. There were $4.77B in debt and $1.75B in liabilities at the time. Its Book Value Per Share was $59.61, while its Total Shareholder’s Equity was $6.56B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DGX is Buy with a score of 3.75.
